18,313 Shares in InMode Ltd. (NASDAQ:INMD) Bought by Teacher Retirement System of Texas

Teacher Retirement System of Texas purchased a new stake in InMode Ltd. (NASDAQ:INMD) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 18,313 shares of the healthcare company’s stock, valued at approximately $306,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. State Street Corp boosted its stake in shares of InMode by 3.7% during the 3rd quarter. State Street Corp now owns 2,044,640 shares of the healthcare company’s stock worth $34,657,000 after acquiring an additional 73,183 shares during the period. Geode Capital Management LLC boosted its position in InMode by 0.6% during the third quarter. Geode Capital Management LLC now owns 1,101,951 shares of the healthcare company’s stock worth $18,678,000 after purchasing an additional 6,282 shares during the period. Systematic Financial Management LP increased its holdings in shares of InMode by 13.3% in the third quarter. Systematic Financial Management LP now owns 982,111 shares of the healthcare company’s stock valued at $16,647,000 after purchasing an additional 115,492 shares during the last quarter. Disciplined Growth Investors Inc. MN raised its position in shares of InMode by 0.4% in the third quarter. Disciplined Growth Investors Inc. MN now owns 808,149 shares of the healthcare company’s stock valued at $13,698,000 after purchasing an additional 3,191 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC lifted its stake in shares of InMode by 12.9% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 720,750 shares of the healthcare company’s stock worth $12,217,000 after buying an additional 82,100 shares during the last quarter. Institutional investors own 68.04% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Barclays upped their price target on shares of InMode from $26.00 to $29.00 and gave the company an “overweight” rating in a research note on Wednesday, February 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of InMode in a research report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, InMode currently has a consensus rating of “Hold” and a consensus price target of $22.25.

InMode Stock Performance

INMD stock opened at $18.10 on Wednesday. InMode Ltd. has a 52 week low of $14.87 and a 52 week high of $20.98. The company has a market capitalization of $1.26 billion, a PE ratio of 7.70 and a beta of 2.08. The company’s 50-day simple moving average is $18.36 and its 200 day simple moving average is $17.80.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.